I’ll avoid the Cineworld share price. Here is a pick from my best stocks to buy now list instead

first_img I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. The Covid-19 pandemic has battered the Cineworld (LSE:CINE) chain. In turn, the Cineworld share price has fallen sharply over the past year or so. With no end to restrictions in sight, I am not willing to gamble any money on CINE. Instead, I really like international packaging firm DS Smith (LSE:SMDS), which is on my best stocks to buy now list.Cineworld share price woesRewind to this time last year, and I could pick up shares in Cineworld for 179p per share. As I write, shares are trading for 73p, which is nearly a 60% decrease. New Covid-19 variants and vaccine rollouts have dominated the headlines in 2021 so far. Despite this gloomy start, the Cineworld share price has enjoyed a better start to 2021. To date, it is up nearly 20% since trading kicked off.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Here’s why I don’t see Cineworld as a viable investment for my portfolio right now. The new Covid-19 strains are concerning and may mean more lockdowns in the future. Next, the Cineworld share price has been battered by to the fact it has had to raise so much money just to keep the lights on. Finally, I feel cinemas have a battle on their hands to regain customers from the streaming giants. Netflix, Amazon, and Disney have all seen hikes in subscription numbers.On the other hand, cinemas could reopen sooner than I expect. And when it does happen, people could flock to the big screen again, eager for an opportunity to get out of the house and enjoy the latest blockbuster with friends.DS SmithIn contrast, I believe DS Smith is a good stock pick right now. Increasing online shopping numbers means there is a huge need for e-commerce, packaging, warehousing, and distribution. Some of my best stocks to buy now are from this category, such as Clipper Logistics and Tritax Big Box REIT. Unlike the Cineworld share price, the DS Smith share price has flourished in recent months. Since the height of the market crash back in March, SMDS is up nearly 40%. SMDS has an industry-leading record of innovation. Many of its packaging products are used across a variety of retail sectors, which helps diversify its offering.In its December half-year report, DS Smith reported it will resume its dividend. In addition, it reported an increase of 16% in cash flow compared to the same period last year. This gives it a robust balance sheet and lots of liquidity. Volume in packaging increased over 3% too.Of course, there is a risk that earnings could come under pressure, especially if a slow economic recovery impacts broader consumer spending levels.Best stocks to buy now or Cineworld gamble?If I were more of a contrarian, I might consider Cineworld. It does have the potential to recover. But the uncertainty in terms of how long it could take unsettles me. As of right now, I’m avoiding the Cineworld share price and instead continuing to investigate picks from my best stocks to buy now list. Here is another from my list I really like. Image source: Getty Images Are you on the lookout for UK growth stocks?If so, get this FREE no-strings report now.While it’s available: you’ll discover what we think is a top growth stock for the decade ahead.And the performance of this company really is stunning.In 2019, it returned £150million to shareholders through buybacks and dividends.We believe its financial position is about as solid as anything we’ve seen.Since 2016, annual revenues increased 31%In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259Operating cash flow is up 47%. (Even its operating margins are rising every year!)Quite simply, we believe it’s a fantastic Foolish growth pick.What’s more, it deserves your attention today.So please don’t wait another moment. Our 6 ‘Best Buys Now’ Shares Get the full details on this £5 stock now – while your report is free. FREE REPORT: Why this £5 stock could be set to surge I’ll avoid the Cineworld share price. Here is a pick from my best stocks to buy now list insteadcenter_img Simply click below to discover how you can take advantage of this. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Jabran Khan | Tuesday, 9th February, 2021 | More on: CINE SMDS Enter Your Email Address Jabran Khan has no position in any shares mentioned. The Motley Fool UK has recommended DS Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. See all posts by Jabran Khanlast_img read more

Postdoctoral Associate (66291)

first_imgThis is a full-time postdoctoral position that is available in theDepartment of Orthodontics at the University of Florida. Theprincipal duties of this position include active participation inlaboratory procedures (animal behavioral testing, histology,surgeries, molecular biology techniques), project management, dataand statistical analyses, and manuscript preparation.Ph.D in Neuroscience, Pharmacology or a related field.Candidates should submit a curriculum vitae, a letter outlininginterests, and a list of three references.Application review will begin immediately and continue until theposition is filled.Final candidate will be required to provide official transcript tothe hiring department upon hire. A transcript will not beconsidered “official” if a designation of “Issued to Student” isvisible. Degrees earned from an education institution outside ofthe United States are required to be evaluated by a professionalcredentialing service provider approved by National Association ofCredential Evaluation Services (NACES), which can be found athttp://www.naces.org/ .The University of Florida is an equal opportunity institutiondedicated to building a broadly diverse and inclusive faculty andstaff.The University of Florida is An Equal Employment OpportunityInstitution. If an accommodation due to a disability is needed toapply for this position, please call 352/392-2477 or the FloridaRelay System at 800/955-8771 (TDD). Hiring is contingent uponeligibility to work in the US. Searches are conducted in accordancewith Florida’s Sunshine Law.The University of Florida is committed to non-discrimination withrespect to race, creed, color, religion, age, disability, sex,sexual orientation, gender identity and expression, marital status,national origin, political opinions or affiliations, geneticinformation and veteran status in all aspects of employmentincluding recruitment, hiring, promotions, transfers, discipline,terminations, wage and salary administration, benefits, andtraining.last_img read more